Citation Impact
Citing Papers
Honokiol: A non-adipogenic PPARγ agonist from nature
2013
Identification of molecular apocrine breast tumours by microarray analysis
2005
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Progesterone resistance in endometriosis: Link to failure to metabolize estradiol
2006
PNU 157706, a novel dual type I and II5α-reductase inhibitor
1998
Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders
2012
Disease-Specific Induced Pluripotent Stem Cells
2008 Standout
Spermatogenesis in fish
2009 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Is dehydroepiandrosterone a hormone?
2005
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
Endometriosis
2009 Standout
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
2014 Standout
International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions
2008
Short-chain dehydrogenases/reductases (SDR)
1995 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets
2012
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium.
1994
Recent advances in the transition metal-catalyzed twofold oxidative C–H bond activation strategy for C–C and C–N bond formation
2011 Standout
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
2016 Standout
Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol1
1998
Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target
1999
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Fish Androgen Receptor: cDNA Cloning, Steroid Activation of Transcription in Transfected Mammalian Cells, and Tissue mRNA Levels
1999
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Sex Steroids and Bone
2002
17β-Hydroxysteroid dehydrogenase 3 deficiency
1996
Pyroptosis: A new frontier in cancer
2019 Standout
Neurosteroid biosynthesis: Enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides
2009
Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/Δ5-Δ4isomerase(3β-HSD), 17β-HSD5α-reductase and aromatase activities in the rhesus monkey
1994
Porcine 80-kDa Protein Reveals Intrinsic 17β-Hydroxysteroid Dehydrogenase, Fatty Acyl-CoA-hydratase/Dehydrogenase, and Sterol Transfer Activities
1996
Consensus Statement on Management of Intersex Disorders
2006 Standout
Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents
2010
Androgen excess: Investigations and management
2016
Endometriosis
2004 Standout
Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
1998
G protein-coupled receptors as targets for anti-diabetic therapeutics
2016
Structural insights for the design of new PPARgamma partial agonists with high binding affinity and low transactivation activity
2011
The art and design of genetic screens: mammalian culture cells
2004
Endometriosis and ovarian cancer: Thoughts on shared pathophysiology
2003
Endometriosis: pathogenesis and treatment
2013 Standout
Polycystic ovary syndrome
2016 Standout
G protein-coupled receptors for energy metabolites as new therapeutic targets
2012
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase
2001
Pentalenolactone biosynthesis: Molecular cloning and assignment of biochemical function to PtlF, a short-chain dehydrogenase from Streptomyces avermitilis, and identification of a new biosynthetic intermediate
2006 StandoutNobel
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
N-Acetylfarnesylcysteine Is a Novel Class of Peroxisome Proliferator-activated Receptor γ Ligand with Partial and Full Agonist Activity in Vitro and in Vivo
2011
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Bond Formations between Two Nucleophiles: Transition Metal Catalyzed Oxidative Cross-Coupling Reactions
2011 Standout
Pathogenesis and pathophysiology of endometriosis
2012 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Characteristics of a Highly Labile Human Type 5 17β-Hydroxysteroid Dehydrogenase1
1999
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
2003
Oxidative Coupling of Indoles with 3-Oxindoles
2010
Sex determination and sex differentiation in fish: an overview of genetic, physiological, and environmental influences
2002 Standout
The chemistry of Cas9 and its CRISPR colleagues
2017 StandoutNobel
Molecular Endocrinology of Hydroxysteroid Dehydrogenases*
1997
Ovarian cancer statistics, 2018
2018 Standout
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Localization of Type 5 17β-Hydroxysteroid Dehydrogenase, 3β-Hydroxysteroid Dehydrogenase, and Androgen Receptor in the Human Prostate by in Situ Hybridization and Immunocytochemistry
1999
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Intercellular signaling of reproductive development by theC. elegansDAF-9 cytochrome P450
2004 StandoutNobel
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
ABSCISIC ACID BIOSYNTHESIS AND CATABOLISM
2005 Standout
NMR structure of the sterol carrier protein-2: implications for the biological role 1 1Edited by P. E. Wright
2000 StandoutNobel
2015
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Controls of Hair Follicle Cycling
2001 Standout
DNA Bending and Wrapping around RNA Polymerase: a “Revolutionary” Model Describing Transcriptional Mechanisms
1999
Three-component domino reaction synthesis of highly functionalized bicyclic pyrrole derivatives
2014
Pyrrole: a resourceful small molecule in key medicinal hetero-aromatics
2015 Standout
Palladium-Catalyzed Regioselective Oxidative Coupling of Indoles and One-Pot Synthesis of Acetoxylated Biindolyls
2009
Expression Cloning of a Novel Estrogenic Mouse 17β-Hydroxysteroid Dehydrogenase/ 17-Ketosteroid Reductase (m17HSD7), Previously Described as a Prolactin Receptor-Associated Protein (PRAP) in Rat
1998
Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
1999
Works of Monica Einstein being referenced
Immunohistochemical Analysis of Steroid 5α‐Reductase Type 1 in Human Scalp and Prostate
1996
Highly functionalized 7-azaindoles as selective PPARγ modulators
2008
The Differential Interactions of Peroxisome Proliferator-Activated Receptor γ Ligands with Tyr473 Is a Physical Basis for Their Unique Biological Activities
2007
Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARγ partial agonists
2005
Selective glucocorticoid receptor nonsteroidal ligands completely antagonize the dexamethasone mediated induction of enzymes involved in gluconeogenesis and glutamine metabolism
2004
Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice
2008
Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity
1993
Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia
2009
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume
2009
Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators
2011